Clinical Trials Directory

Trials / Terminated

TerminatedNCT04495673

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcrancial direct current stimulation (tDCS) for new addiction treatments that support long-term abstinence. This study will investigate whether the pairing of dorsolateral prefrontal cortex (DLPFC) stimulation and cognitive training can enhance functional connectivity between DLPFC and nucleus accumbens (NAcc). We have identified higher functional connectivity between DLPFC and NAcc in alcoholics that have successfully maintained abstinence for extended periods of time (7 years). This paired-neuromodulation approach can potentially be used as a therapeutic intervention to decrease substance use probability in addiction (e.g. opioid use disorder). The long term goal is to develop new addiction treatments that support long-term abstinence in opioid use disorder. The overall objective of this proposal is to enhance functional connectivity between DLPFC and NAcc as a therapeutic intervention to enhance cognition and reduce substance use rates in opioid use disorder.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Direct Current Stimulation (tDCS)Participants receive 10 sessions (2 5-visit blocks of 46 minutes) of active tDCS to DLPFC (dorsolateral prefrontal cortex)
DEVICESham Transcranial Direct Current Stimulation (tDCS)Participants receive 10 sessions (1 5-visit block of 46 minutes of active tDCS and 1 5-visit block of sham tDCS)
BEHAVIORALCognitive TrainingExecutive functioning tasks

Timeline

Start date
2021-01-11
Primary completion
2022-02-22
Completion
2022-02-22
First posted
2020-08-03
Last updated
2025-07-10
Results posted
2025-07-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04495673. Inclusion in this directory is not an endorsement.